Prenetics Global Limited - Ordinary Shares - Class A

NASDAQ:PRE   4:00:00 PM EDT
7.91
-0.37 (-4.47%)
4:04:12 PM EDT: $7.91 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)98.49M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$21.7 Million
Adjusted EPS-$0.71
See more estimates
10-Day MA$8.19
50-Day MA$7.33
200-Day MA$5.42
See more pivots

Prenetics Global Limited - Ordinary Shares - Class A Stock, NASDAQ:PRE

Unit 703-706, K11 Atelier Kings Rd, 728 Kings Road, Hong Kong, George Town KY1-1106
Hong Kong
Phone: +852.2210.9588
Number of Employees: 324

Description

Prenetics Global Limited is a health sciences company, which engages in the provision of early detection, prevention, and treatment of cancer. The firm offers products and services under the brands of CircleDNA, Insighta, ACT Genomics, IM8, and Europa. IM8, a health and wellness brand which focuses on consumer health products. Europa, a U.S. sports distribution company. Insighta, a venture which focuses on the development of early cancer detection technologies. It also focuses on its CircleDNA and ACT Genomics business units. The CircleDNA business unit uses next-generation sequencing (NGS) technology for consumer deoxyribonucleic acid (DNA) test. The ACT Genomics business unit is involved in genomic profiling of solid tumors. It has a presence in the United States. The company was founded by Sheng Wu Yeung and Chi Hung Tzang in 2014 and is headquartered in Hong Kong.